Algernon Pharmaceuticals Inc (AGNPF)

[bettingonbayst]

Over promise, under deliver. This is what I see here, and nobody is to blame outside of management.

We saw it with the South Korea trial, and now we are seeing it with the highly anticipated 2b/3 trial. Christopher Morneau has touted an expected "first patient enrolled" before the end of July for the past 6 weeks. It is now the last trading day in July and still no news.

Let me repeat: Over promise, under deliver

It is managements responsibility to execute on delivery dates at which they made. If there is any doubt that a date cannot be obtained, it is then management's responsibility to give the market a new date of which is achievable.

This isn't rocket science.

AGN/PF's price will now sink lower if news doesn't come by 4pm, and it (the price) should! Chris wants new investment in this company, but fails to deliver whilst giving market expectations.

Still Long, but deeply disappointed.

B. O. B.